It seems three biotech stocks may be poised to break out. Find out which stocks to put on your radar right now.
Investors ought to get ready for a bull market, said Brian Belski, chief investment strategist at Oppenheimer & Co. and Art Nunes, market strategist at IMS Capital Management. They shared their take on the markets with investors.
Markets are likely to end the year higher and investors need some strong, blue-chip stocks in their portfolios, to counteract the volatility shown by cyclical shares, Bob Doll, global chief investment officer of equities at BlackRock, told CNBC Tuesday.
Stocks ended flat Tuesday as investors took a breather after Monday's blockbuster rally.
Stocks struggled to stay in positive territory for any length of time Tuesday as profit-taking after Monday's blockbuster rally overshadowed a fifth-straight rise in pending-home sales.
Stocks bounced back from a lower open Tuesday after a surprisingly sharp jump in pending-home sales.
Futures suggested stock would retreat Tuesday after a milestone session on Monday that sent the S&P over 1,000 for the first time since November.
Everyone’s talking about the July stock market rally. And, of course, you can’t overlook the outperformance of biotech—big and small.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
The bulls just can't drive the market beyond its 9-month high. Is a correction coming?
Stocks ended slightly lower Tuesday, though the Nasdaq eked out a gain. And Citigroup shares soared.
Stocks skidded Tuesday after a report showed consumer confidence is waning amid worries about the job market. It was a struggle all morning as investors juggled another batch of disappointing earnings results against an encouraging report on the housing market.
After a huge two week really, is Tuesday's market weakness an early sign of a sharp pull back or nothing more than expected profit taking?
So far this quarter, only one S&P healthcare company, Aetna, has missed its consensus EPS estimate. This week there are over 20 more healthcare companies reporting. Yesterday after the bell Amgen blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals beat by three cents per share.
Stock futures drifted slightly lower ahead of the open Tuesday as investors waited for the next batch of earnings and key economic data.
In the final minutes of trading the bulls foiled the bears and sent both the S&P 500 and Dow higher as investors rotated into financials...
Stocks eked out a gain Monday as banks got a boost from a jump in new-home sales. Stocks had struggled for much of the day as investors worried about a a record $200 billion in Treasury auctions this week and lowered outlooks from Honeywell and Aetna cast a shadow over the market.
The Dow poked into positive territory Monday afternoon, led by Bank of America, as a jump in new-home sales buoyed bank stocks. Still, the blue-chip index struggled to stay above water as worries about a record $200 billion in Treasury auctions this week and lowered outlooks from Honeywell and Aetna cast a shadow over the market.
With nearly 150 more companies due to flood the Street with earnings the bulls appear to be getting a little tired. Is this the pause that refreshes or are investors growing concerned?
Opposition to the Obama administration's health care plan had a new voice Monday, as the U.S. Chamber of Commerce launched a critical ad campaign suggesting alternatives. But John Sullivan of Leerink Swann says this is a great time to buy health stocks.